Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands

The Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA) demonstrated the efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) in preventing vaccine-type community-acquired pneumonia and vaccine-type invasive pneumococcal disease in elderly subjects. We examined the cost-effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangen, Marie-Josée J., Rozenbaum, Mark H., Huijts, Susanne M., van Werkhoven, Cornelis H., Postma, Douwe F., Atwood, Mark, van Deursen, Anna M.M., van der Ende, Arie, Grobbee, Diederick E., Sanders, Elisabeth A.M., Sato, Reiko, Verheij, Theo J.M., Vissink, Conrad E., Bonten, Marc J.M., de Wit, G. Ardine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750466/
https://www.ncbi.nlm.nih.gov/pubmed/26160871
http://dx.doi.org/10.1183/13993003.00325-2015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750466/
https://www.ncbi.nlm.nih.gov/pubmed/26160871
http://dx.doi.org/10.1183/13993003.00325-2015

Ejemplares similares